Actively Recruiting
Evaluating Two Dose Levels of Inavolisib with Fulvestrant for PIK3CA-Mutated HR-Positive HER2-Negative Locally Advanced or Metastatic Breast Cancer
Led by Hoffmann-La Roche · Updated on 2026-11-03
80
Participants Needed
34
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of two different doses of inavolisib combined with fulvestrant in adults with PIK3CA-mutated, hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer who have previously been treated with cyclin-dependent kinase inhibitors. This phase II trial aims to compare these combinations to better understand their impact on this specific breast cancer type. Participants will receive oral inavolisib tablets alongside fulvestrant administered by intramuscular injection. The study involves two experimental groups, each receiving a different dose level of inavolisib combined with fulvestrant. Treatments are given according to a schedule defined in the study protocol, and participants are randomly assigned to one of these groups. During the trial, participants will undergo evaluations to measure tumor response and monitor any side effects over approximately two years. Researchers will track outcomes such as objective response rate, duration and time to response, progression-free survival, and treatment-related adverse events. Patient-reported outcomes concerning symptoms and quality of life will also be collected. Safety monitoring will continue throughout the treatment and follow-up periods to assess the impact of the study drugs.
CONDITIONS
Brief Title
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
Research Team
R
Reference Study ID Number: WO46063 https://forpatients.roche.com/ No attachments to email below.
F
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here